CIK 0001631574 · Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-25 | Moran Kyle Chief Financial Officer | Sale 10b5-1 | −17,146 | $9.00 | $154K | 19,777 |
| 2024-08-21 | BOLNO PAUL President and CEO | Sale 10b5-1 | −48,366 | $5.78 | $280K | 359,059 |
| 2024-08-12 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award | +16,115 | 16,115 | ||
| 2024-08-12 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Share Option (Right to Buy) | +32,230 | 32,230 | ||
| 2024-08-12 | Rawcliffe Adrian Director | Grant or award | +16,115 | 16,115 | ||
| 2024-08-12 | Rawcliffe Adrian Director | Grant or award · Share Option (right to buy) | +32,230 | 32,230 | ||
| 2024-08-12 | Tan Aik Na Director | Grant or award | +16,115 | 16,115 | ||
| 2024-08-12 | Tan Aik Na Director | Grant or award · Share Option (right to buy) | +32,230 | 32,230 | ||
| 2024-08-12 | HENRY CHRISTIAN O Director | Grant or award | +16,115 | 16,115 | ||
| 2024-08-12 | HENRY CHRISTIAN O Director | Grant or award · Share Option (right to buy) | +32,230 | 32,230 | ||
| 2024-08-12 | CORRIGAN MARK Director | Grant or award | +32,230 | 32,230 | ||
| 2024-08-12 | CORRIGAN MARK Director | Grant or award · Share Option (right to buy) | +64,460 | 64,460 | ||
| 2024-08-12 | Verdine Gregory L. Director | Grant or award | +16,115 | 46,115 | ||
| 2024-08-12 | Verdine Gregory L. Director | Grant or award · Share Option (right to buy) | +32,230 | 32,230 | ||
| 2024-08-12 | Wagner Heidi L Director | Grant or award | +32,230 | 32,230 | ||
| 2024-08-12 | Wagner Heidi L Director | Grant or award · Share Option (right to buy) | +64,460 | 64,460 | ||
| 2024-08-12 | TAKANASHI KEN Director | Grant or award | +16,115 | 5,721,175 | ||
| 2024-08-12 | TAKANASHI KEN Director | Grant or award · Share Option (right to buy) | +32,230 | 32,230 | ||
| 2024-07-22 | Vargeese Chandra See Remarks | Option exercise | +68,210 | $2.48 | $169K | 185,061 |
| 2024-07-22 | Vargeese Chandra See Remarks | Option exercise · Share Option (right to buy) | −68,210 | 75,332 |
Page 11 of 13 · 255 trades